Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;13(3):266-75.
doi: 10.1016/j.jpain.2011.11.004. Epub 2012 Jan 29.

Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors

Kathleen W Saunders  1 , Michael Von Korff, Cynthia I Campbell, Caleb J Banta-Green, Mark D Sullivan, Joseph O Merrill, Constance Weisner
Affiliations

Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors

Kathleen W Saunders et al. J Pain. 2012 Mar.

Abstract

Taking opioids with other central nervous system (CNS) depressants can increase risk of oversedation and respiratory depression. We used telephone survey and electronic health care data to assess the prevalence of, and risk factors for, concurrent use of alcohol and/or sedatives among 1,848 integrated care plan members who were prescribed chronic opioid therapy (COT) for chronic noncancer pain. Concurrent sedative use was defined by receiving sedatives for 45+ days of the 90 days preceding the interview; concurrent alcohol use was defined by consuming 2+ drinks within 2 hours of taking an opioid in the prior 2 weeks. Some analyses were stratified by substance use disorder (SUD) history (alcohol or drug). Among subjects with no SUD history, 29% concurrently used sedatives versus 39% of those with an SUD history. Rates of concurrent alcohol use were similar (12 to 13%) in the 2 substance use disorder strata. Predictors of concurrent sedative use included SUD history, female gender, depression, and taking opioids at higher doses and for more than 1 pain condition. Male gender was the only predictor of concurrent alcohol use. Concurrent use of CNS depressants was common among this sample of COT users regardless of substance use disorder status.

Perspective: Risks associated with concurrent use of CNS depressants are not restricted to COT users who abuse those substances. And, the increased risk of concurrently using CNS depressants is not restricted to opioid users with a prior SUD history. COT requires close monitoring, regardless of substance use disorder history.

PubMed Disclaimer

References

    1. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943–53. - PubMed
    1. Banta-Green C, Jackson TR, Albert DH, Hanrahan M, Taylor M, Freng S, Ohta J, Soukup M, Miller G, Smith R, Forbes A, Harruff R, Reid S, Finney E. [July 20, 2011];Recent Drug Abuse Trends in Seattle-King County in Proceedings of the National Institute on Drug Abuse's Community Epidemiology Work Group Report, Volume II, June 2010. 2011 http://www.drugabuse.gov/PDF/CEWG/CEWG-June-2010-VolII-508.pdf.
    1. Banta-Green C, Merrill J, Doyle S, Boudreau D, Calsyn D. Opioid use behaviors, mental health and pain—Development of a typology of chronic pain patients. Drug and Alcohol Dependence. 2009;104:34–42. - PMC - PubMed
    1. Bohnert A, Valenstein M, Bair M, Ganoczy D, McCarthy J, Hgen M, Blow F. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–1321. - PubMed
    1. Boscarino J, Rukstalis M, Hoffman S, Han J, Erlich P, Gerhard G, Stewart W. Risk factors for drug dependence among outpatients on opioid therapy in a large UW healthcare system. Addiction. 2010;105(10):1776–1782. - PubMed

Publication types